Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials
Journal article
Rivellese F. et al, (2023), The lancet rheumatology, 5, e648 - e659
Author Correction: Inflammation across tissues: can shared cell biology help design smarter trials?
Journal article
Hosack T. et al, (2023), Nat rev rheumatol
A roadmap for delivering a human musculoskeletal cell atlas.
Journal article
Baldwin M. et al, (2023), Nat rev rheumatol
Inflammation across tissues: can shared cell biology help design smarter trials?
Journal article
Hosack T. et al, (2023), Nat rev rheumatol, 19, 666 - 674
Three-dimensional, in-vitro approaches for modelling soft-tissue joint diseases
Journal article
Johnson PA. et al, (2023), The lancet rheumatology, 5, e553 - e563
Cellular characterisation of advanced osteoarthritis knee synovium.
Journal article
Mimpen JY. et al, (2023), Arthritis res ther, 25
Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups.
Journal article
Clark KEN. et al, (2023), Ann rheum dis
Number of days required to measure sedentary time and physical activity using accelerometery in rheumatoid arthritis: a reliability study.
Journal article
O'Brien CM. et al, (2023), Rheumatol int
Why does understanding the biology of fibroblasts in immunity really matter?
Journal article
Wong ZY. et al, (2023), Plos biol, 21
Primed to resolve: A single cell atlas of the shoulder capsule reveals a cellular basis for resolving inflammatory fibrosis
Preprint
Ng MTH. et al, (2023)
Defining the transcriptional landscape of developing human tendons
Conference paper
Kurjan A. et al, (2023), International journal of experimental pathology, 104, A4 - A5
Differential effect of lactate on synovial fibroblast and macrophage effector functions.
Journal article
Pucino V. et al, (2023), Front immunol, 14
Fibroblast heterogeneity: Keystone of tissue homeostasis and pathology in inflammation and ageing.
Journal article
Gauthier V. et al, (2023), Front immunol, 14
"Your people have always been servants": internalised racism in academic medicine.
Journal article
Mehta P. and Buckley CD., (2022), Lancet, 400, 2045 - 2046
Mesenchymal cells in health and disease
Journal article
Koliaraki V. et al, (2022), Nature immunology
Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases.
Journal article
Korsunsky I. et al, (2022), Med (n y), 3, 481 - 518.e14
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming.
Journal article
Cooles FAH. et al, (2022), Ann rheum dis, 81, 1214 - 1223
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction.
Journal article
Nayar S. et al, (2022), Commun biol, 5
Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance.
Journal article
Aiyegbusi OL. et al, (2022), Trials, 23
DEFINING DISTINCT RESIDENT AND MIGRATORY FIBROBLAST POPULATIONS FROM SKIN BIOPSIES IN SYSTEMIC SCLEROSIS
Conference paper
Clark K. et al, (2022), Annals of the rheumatic diseases, 81, 495 - 496